Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Pharma's 'urgent need for reinvention': PwC's call to action
PwC has laid out bold ambitions for what it believes drugmakers could achieve by 2035, as well as steps those companies should start taking in 2026.
Fraiser Kansteiner
Jan 8, 2026 6:00am
WEP Clinical widens reach with European CRO buy
Jan 7, 2026 2:55pm
Amgen weaves in UK biotech with up to $840M acquisition
Jan 6, 2026 10:35am
Xoma adds another struggling biotech to its buyout roster
Dec 16, 2025 11:00am
Gone are the bear days for biotech? William Blair thinks so
Dec 12, 2025 10:55am
Cycle Pharma scoops up beleaguered rare disease biotech
Dec 12, 2025 9:55am
